Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 13B (ANKRD13B) is a cytoplasmic protein containing multiple ankyrin repeats, acting primarily as a ubiquitin-binding scaffold that recognizes 'Lys-63'-linked ubiquitin but not 'Lys-48'-linked chains. It participates in the negative regulation of receptor internalization, notably for the epidermal growth factor receptor (EGFR), by transiently promoting complex formation with molecular partners to facilitate receptor trafficking. The protein is found mainly in endosomes, the perinuclear region, and the plasma membrane, and although its involvement in receptor trafficking suggests possible relevance in disease contexts such as cancer and neuropsychiatric disorders, it is not currently classified as a therapeutic target for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 13B (ANKRD13B).